share_log

重药控股(000950.SZ)控股子公司重药股份获药品注册证书

Heavy Pharmaceutical Co., Ltd., a subsidiary of Heavy Pharmaceutical Holdings (000950.SZ), obtained a drug registration certificate

Zhitong Finance ·  Mar 11 18:53

Heavy Pharmaceutical Holdings (000950.SZ) announced that Chongqing Pharmaceutical (Group) Co., Ltd., a holding subsidiary of the company...

Zhitong Finance App News, Heavy Pharmaceutical Holdings (000950.SZ) announced that Chongqing Pharmaceutical (Group) Co., Ltd. (“Heavy Pharmaceutical Co., Ltd.”), a holding subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The drug name is Pregabalin capsules, which are mainly used to treat post-herpes zoster neuralgia and fibromyalgia.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment